These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24232077)

  • 21. Liquisolid technique to enhance and to sustain griseofulvin dissolution: effect of choice of non-volatile liquid vehicles.
    Elkordy AA; Essa EA; Dhuppad S; Jammigumpula P
    Int J Pharm; 2012 Sep; 434(1-2):122-32. PubMed ID: 22677418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of Loperamide Dissolution Rate by Liquisolid Compact Technique.
    Venkateswarlu K; Preethi JK; Chandrasekhar KB
    Adv Pharm Bull; 2016 Sep; 6(3):385-390. PubMed ID: 27766222
    [No Abstract]   [Full Text] [Related]  

  • 23. Formulation and optimization of liquisolid compact for enhancing dissolution properties of efavirenz by using DoE approach.
    Jaydip B; Dhaval M; Soniwala MM; Chavda J
    Saudi Pharm J; 2020 Jun; 28(6):737-745. PubMed ID: 32550806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of powder substrate on the dissolution properties of methyclothiazide liquisolid compacts.
    Spireas S; Wang T; Grover R
    Drug Dev Ind Pharm; 1999 Feb; 25(2):163-8. PubMed ID: 10065349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro release evaluation of hydrocortisone liquisolid tablets.
    Spireas S; Sadu S; Grover R
    J Pharm Sci; 1998 Jul; 87(7):867-72. PubMed ID: 9649356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formulation and evaluation of liquisolid compacts of itraconazole to enhance its oral bioavailability.
    Thakkar HP; Vasava D; Patel AA; Dhande RD
    Ther Deliv; 2020 Feb; 11(2):83-96. PubMed ID: 31955698
    [No Abstract]   [Full Text] [Related]  

  • 27. Enhanced Oral Bioavailability of Etodolac by the Liquisolid Compact Technique: Optimisation, In-Vitro and In-Vivo Evaluation.
    Pathak BK; Raghav M; Thakkar AR; Vyas BA; Shah PJ
    Curr Drug Deliv; 2021; 18(4):471-486. PubMed ID: 33106143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of Itraconazole Liquisolid Compact: Effect of Polyvinylpyrrolidone on the Dissolution Properties.
    Gong W; Wang Y; Sun L; Yang J; Shan L; Yang M; Gao C
    Curr Drug Deliv; 2016; 13(3):452-61. PubMed ID: 26882116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Liquisolid technique for enhancement of dissolution prosperities of tanshinone II(A)].
    Liu XQ; Meng QJ; Xu XL; Zhao J; Yang H; Yi H
    Zhongguo Zhong Yao Za Zhi; 2015 Dec; 40(24):4840-6. PubMed ID: 27245032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of some commercial grades of microcrystalline cellulose on flowability, compressibility, and dissolution profile of piroxicam liquisolid compacts.
    Javadzadeh Y; Shariati H; Movahhed-Danesh E; Nokhodchi A
    Drug Dev Ind Pharm; 2009 Feb; 35(2):243-51. PubMed ID: 18785038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of ketoconazole dissolution rate by the liquisolid technique.
    Molaei MA; Osouli-Bostanabad K; Adibkia K; Shokri J; Asnaashari S; Javadzadeh Y
    Acta Pharm; 2018 Sep; 68(3):325-336. PubMed ID: 31259692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices.
    Javadzadeh Y; Musaalrezaei L; Nokhodchi A
    Int J Pharm; 2008 Oct; 362(1-2):102-8. PubMed ID: 18647643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Investigation into the Influence of Process Parameters and Formulation Variables on Compaction Properties of Liquisolid Systems.
    Aleksić I; German Ilić I; Cvijić S; Parojčić J
    AAPS PharmSciTech; 2020 Aug; 21(7):242. PubMed ID: 32839881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EVALUATION OF SORPTIVE PROPERTIES OF VARIOUS CARRIERS AND COATING MATERIALS FOR LIQUISOLID SYSTEMS.
    Vraníková B; Gajdziok J
    Acta Pol Pharm; 2015; 72(3):539-49. PubMed ID: 26642662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of biorelevant media for assessment of a poorly soluble weakly basic drug in the form of liquisolid compacts: in vitro and in vivo study.
    Badawy MA; Kamel AO; Sammour OA
    Drug Deliv; 2016; 23(3):818-27. PubMed ID: 24892630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of a liquisolid technique to cannabis sativa extract compacts: Effect of liquid vehicles on the dissolution enhancement and stability of cannabinoids.
    Jaipakdee N; Tabboon P; Limpongsa E
    Int J Pharm; 2022 Jan; 612():121277. PubMed ID: 34774694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the effect of carrier material on modification of release characteristics of poor water soluble drug from liquisolid compacts.
    Ali B; Khan A; Alyami HS; Ullah M; Wahab A; Badshah M; Naz A
    PLoS One; 2021; 16(8):e0249075. PubMed ID: 34339440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liquisolid compacts: the effect of cosolvent and HPMC on theophylline release.
    Nokhodchi A; Aliakbar R; Desai S; Javadzadeh Y
    Colloids Surf B Biointerfaces; 2010 Aug; 79(1):262-9. PubMed ID: 20451361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissolution Enhancement of Rosuvastatin Calcium by Liquisolid Compact Technique.
    Kapure VJ; Pande VV; Deshmukh PK
    J Pharm (Cairo); 2013; 2013():315902. PubMed ID: 26555972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation and Characterization of Self-Microemulsifying Drug Delivery System of Olmesartan Medoxomil for Bioavailability Improvement.
    Prajapati ST; Joshi HA; Patel CN
    J Pharm (Cairo); 2013; 2013():728425. PubMed ID: 26555991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.